Toggle Offcanvas
...
 
Beclomethasone Tenders

Beclomethasone Tenders

View Beclomethasone tenders, RFPs and contracts. Bid on readily available Beclomethasone tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Beclomethasone tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Beclomethasone.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Beclomethasone market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Beclomethasone tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

51 Live Notices for Beclomethasone Tenders

Showing 1 to 20

Specific Contracting For The Supply Of Active Ingredients “Beclometasone + Formoterol + Glycopyrronium Different Dosages”, Divided Into 2 Lots, Through The Use Of The Sintel Platform Within The Dynamic Acquisition System For The Supplies Of Pharmaceutical Products “Aria2020305”. Period 12 Months.
country Italy
posting date31 Jan 2025
deadline14 Feb 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Beclometasone/Formoterol (Atc Code According To Who: R03Ak08)
country Germany
posting date28 Jan 2025
deadline30 Nov 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (Atc Code According To Who: R03Al09)
country Germany
posting date04 Dec 2024
deadline31 Jan 2027
Medicines Containing The Active Ingredient Combination Formoterol And Beclometasone (Atc: R03Ak08 - In The Strength 100/6 Micrograms
country Germany
posting date14 Nov 2024
deadline31 Mar 2025
Medicines Containing The Active Ingredient Combination Formoterol And Beclometasone (Atc: R03Ak08 - In The Strength 200/6 Micrograms)
country Germany
posting date13 Nov 2024
deadline31 Oct 2026
Pharmaceutical Discount Agreements From 01.01.2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date11 Nov 2024
deadline02 Nov 2026
Pharmaceutical Discount Agreements From 01.01.2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date11 Nov 2024
deadline02 Nov 2026

Share Share this page